Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oncodesign Precision Medicine
ALOPMCurrent price
1.09 EUR
+0.04 EUR (+3.81%)
Last closed
1.08 EUR
Company
opm.oncodesign.com
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Paris
Capitalization
19 977 240 EUR
Yield for 12 month
-51.77 %
1Y
3Y
5Y
10Y
15Y
ALOPM
Oncodesign Precision Medicine Société anonyme, a biopharmaceutical company, engages in the precision medicine business. The company's pipeline includes OPM-101, a potentially inhibitor of the RIPK2 target, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; OPM-102, a novel inhibitor that is in preclinical studies for the treatment of cancer; and OPM-201, a potential LRRK2 inhibitor, which is in Phase 1 clinical trial for the treatment of Parkinson's disease. It is also developing drugs for the treatment of pancreatic and other cancers. The company has a strategic collaboration agreement with Navigo Proteins GmbH for the discovery and development of new systemic radiotheranostic agents. Oncodesign Precision Medicine Société anonyme was founded in 1995 and is based in Dijon, France. Address: 18 rue Jean Mazen, Dijon, France, 21000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2.27 EURP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures ALOPM
1 year
3 years
5 years
10 years
EBITDA
-9 068 538 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-35.51 %
PEG Ratio
–
Return On Equity TTM
-104.58 %
Wall Street Target Price
2.27 EUR
Revenue TTM
1 351 537 EUR
Book Value
0.22 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-40 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.45 EUR
Diluted Eps TTM
-0.45 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALOPM
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
–Dividend History ALOPM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ALOPM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
41.5742
Price Sales TTM
14.7811
Enterprise Value EBITDA
-5.4493
Price Book MRQ
5.2181
Financials ALOPM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALOPM
For 52 weeks
0.93 EUR
2.29 EUR
50 Day MA
1.15 EUR
Shares Short Prior Month
–
200 Day MA
1.25 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart